BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vries AC, Haringsma J, Kuipers EJ. The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection. Helicobacter 2007;12. [DOI: 10.1111/j.1523-5378.2007.00475.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12:135-138. [PMID: 24107396 DOI: 10.1016/j.cgh.2013.09.064] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
2 Leone P, Vacca A, Dammacco F, Racanelli V. Common Variable Immunodeficiency and Gastric Malignancies. Int J Mol Sci 2018;19:E451. [PMID: 29393912 DOI: 10.3390/ijms19020451] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
3 Chatelain D, Attencourt C, Flejou J. Les classifications des gastrites: mise au point. Revue Francophone des Laboratoires 2014;2014:31-40. [DOI: 10.1016/s1773-035x(14)72313-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Liu W, Pan HF, Wang Q, Zhao ZM. The application of transgenic and gene knockout mice in the study of gastric precancerous lesions. Pathol Res Pract 2018;214:1929-39. [PMID: 30477641 DOI: 10.1016/j.prp.2018.10.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Marcos-pinto R, Dinis-ribeiro M, Carneiro F, Wen X, Lopes C, Figueiredo C, Machado JC, Ferreira RM, Reis CA, Canedo P, Durães C, Ferreira J, Pedroto I, Areias J. First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch 2013;463:391-9. [DOI: 10.1007/s00428-013-1458-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37:375-382. [PMID: 23216458 DOI: 10.1111/apt.12177] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 9.0] [Reference Citation Analysis]
7 Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Moreira-Dias L. We would welcome guidelines for surveillance of patients with gastric atrophic chronic and intestinal metaplasia! Helicobacter 2008;13:75-6. [PMID: 18205670 DOI: 10.1111/j.1523-5378.2008.00589.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133:659-672. [PMID: 17681184 DOI: 10.1053/j.gastro.2007.06.026] [Cited by in Crossref: 420] [Cited by in F6Publishing: 377] [Article Influence: 30.0] [Reference Citation Analysis]
9 Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K, Murawaki Y. Premalignant lesions in gastric cancer. Clin J Gastroenterol 2010;3:6-12. [PMID: 26189899 DOI: 10.1007/s12328-009-0130-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol. 2013;27:205-223. [PMID: 23809241 DOI: 10.1016/j.bpg.2012.12.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
11 Shin WG, Kim HU, Song HJ, Hong SJ, Shim KN, Sung IK, Kim JG. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci. 2012;57:746-752. [PMID: 21984437 DOI: 10.1007/s10620-011-1919-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
12 Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer 2010;116:2941-53. [PMID: 20564399 DOI: 10.1002/cncr.25030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
13 Li H, Jasper H. Gastrointestinal stem cells in health and disease: from flies to humans. Dis Model Mech 2016;9:487-99. [PMID: 27112333 DOI: 10.1242/dmm.024232] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 16.4] [Reference Citation Analysis]
14 Capelle LG, de Vries AC, Haringsma J, Steyerberg EW, Looman CW, Nagtzaam NM, van Dekken H, ter Borg F, de Vries RA, Kuipers EJ. Serum levels of leptin as marker for patients at high risk of gastric cancer. Helicobacter. 2009;14:596-604. [PMID: 19889078 DOI: 10.1111/j.1523-5378.2009.00728.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
15 González CA, Pardo ML, Liso JM, Alonso P, Bonet C, Garcia RM, Sala N, Capella G, Sanz-Anquela JM. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Int J Cancer. 2010;127:2654-2660. [PMID: 20178099 DOI: 10.1002/ijc.25273] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
16 de Vries AC, Haringsma J, de Vries RA, Ter Borg F, van Grieken NC, Meijer GA, van Dekken H, Kuipers EJ. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter. 2010;15:259-264. [PMID: 20633186 DOI: 10.1111/j.1523-5378.2010.00760.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
17 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 90] [Article Influence: 14.7] [Reference Citation Analysis]
18 Olmez S, Aslan M, Erten R, Sayar S, Bayram I. The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes. Gastroenterol Res Pract. 2015;2015:434039. [PMID: 26635875 DOI: 10.1155/2015/434039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
19 Jiang J, Shen S, Dong N, Liu J, Xu Q, Sun L, Yuan Y. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases. Cancer Med 2018;7:4068-76. [PMID: 29963765 DOI: 10.1002/cam4.1615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmunity Reviews 2019;18:215-22. [DOI: 10.1016/j.autrev.2018.08.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
21 Watari J, Tomita T, Tozawa K, Oshima T, Fukui H, Miwa H. Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin. Gut Liver 2020;14:281-90. [PMID: 31547640 DOI: 10.5009/gnl19079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Lee HJ, Lee YJ, Lee JY, Kim ES, Chung WJ, Jang BK, Park KS, Hwang JS, Cho KB. Characteristics of Synchronous and Metachronous Multiple Gastric Tumors after Endoscopic Submucosal Dissection of Early Gastric Neoplasm. Clin Endosc 2018;51:266-73. [PMID: 29621878 DOI: 10.5946/ce.2017.109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
23 Nogueira Tde B, Artigiani R Neto, Herani B Filho, Waisberg J. H. PYLORI INFECTION, ENDOSCOPIC, HISTOLOGICAL ASPECTS AND CELL PROLIFERATION IN THE GASTRIC MUCOSA OF PATIENTS SUBMITTED TO ROUX-EN-Y GASTRIC BYPASS WITH CONTENTION RING: a cross sectional endoscopic and immunohistochemical study. Arq Gastroenterol 2016;53:55-60. [PMID: 27281506 DOI: 10.1590/S0004-28032016000100011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Nguyen PM, Putoczki TL. Could the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer? Cytokine 2019;118:8-18. [PMID: 29396054 DOI: 10.1016/j.cyto.2018.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer. 2009;124:157-166. [PMID: 18823009 DOI: 10.1002/ijc.23864] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
26 Balakrishnan M, George R, Sharma A, Graham DY. Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep 2017;19:36. [PMID: 28730504 DOI: 10.1007/s11894-017-0575-8] [Cited by in Crossref: 118] [Cited by in F6Publishing: 112] [Article Influence: 29.5] [Reference Citation Analysis]
27 Kadurei F, Alboraie M. Case of gastric intestinal metaplasia in an old patient with previous gastric surgery. BMJ Case Rep 2016;2016:bcr2016216556. [PMID: 27558191 DOI: 10.1136/bcr-2016-216556] [Reference Citation Analysis]
28 Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X, Tian SB, Yan C. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0142080. [PMID: 26556485 DOI: 10.1371/journal.pone.0142080] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 9.7] [Reference Citation Analysis]
29 Liu H, Merrell DS, Semino-Mora C, Goldman M, Rahman A, Mog S, Dubois A. Diet synergistically affects helicobacter pylori-induced gastric carcinogenesis in nonhuman primates. Gastroenterology. 2009;137:1367-1379.e1-6. [PMID: 19622359 DOI: 10.1053/j.gastro.2009.07.041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
30 Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Machado JC, Figueiredo C, Reis CA, Ferreira J, Areias J. First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies? Fam Cancer 2012;11:137-43. [PMID: 22057474 DOI: 10.1007/s10689-011-9488-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
31 Xirouchakis E, Laoudi F, Tsartsali L, Spiliadi C, Georgopoulos SD. Screening for Gastric Premalignant Lesions with Narrow Band Imaging, White Light and Updated Sydney Protocol or Both? Dig Dis Sci 2013;58:1084-90. [DOI: 10.1007/s10620-012-2431-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
32 Camacho-Gomez SM, Bernieh A, Saad AG, Tipnis NA. Non-Helicobacter pylori Gastric Intestinal Metaplasia in Children: A Series of Cases and Review of the Literature. Case Rep Gastrointest Med 2018;2018:5930415. [PMID: 29850294 DOI: 10.1155/2018/5930415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 White JR, Sami SS, Reddiar D, Mannath J, Ortiz-Fernández-Sordo J, Beg S, Scott R, Thiagarajan P, Ahmad S, Parra-Blanco A, Kasi M, Telakis E, Sultan AA, Davis J, Figgins A, Kaye P, Robinson K, Atherton JC, Ragunath K. Narrow band imaging and serology in the assessment of premalignant gastric pathology. Scand J Gastroenterol 2018;53:1611-8. [PMID: 30600732 DOI: 10.1080/00365521.2018.1542455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
34 Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC, Kuipers EJ. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150-1158. [PMID: 20381801 DOI: 10.1016/j.gie.2009.12.029] [Cited by in Crossref: 241] [Cited by in F6Publishing: 225] [Article Influence: 21.9] [Reference Citation Analysis]
35 Shao L, Li P, Ye J, Chen J, Han Y, Cai J, Lu X. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;. [PMID: 29707766 DOI: 10.1002/ijc.31571] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
36 Piazuelo MB, Camargo MC, Mera RM, Delgado AG, Peek RM, Correa H, Schneider BG, Sicinschi LA, Mora Y, Bravo LE. Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesis. Hum Pathol. 2008;39:1360-1369. [PMID: 18614201 DOI: 10.1016/j.humpath.2008.01.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
37 Song JH, Kim SG, Jin EH, Lim JH, Yang SY. Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy. Gut Liver 2017;11:612-9. [PMID: 28531911 DOI: 10.5009/gnl16488] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
38 Zulfiqar M, Bhalla A, Weindel M, Shidham VB. Molecular diagnostics in esophageal and gastric neoplasms. Clin Lab Med. 2013;33:867-873. [PMID: 24267191 DOI: 10.1016/j.cll.2013.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lee T, Wang R, Lee Y, Lin J, Ho HJ, Hsieh M, Wu C. The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort Study. Journal of Clinical Gastroenterology 2016;50:532-7. [DOI: 10.1097/mcg.0000000000000406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
40 González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133:1023-1032. [PMID: 23280711 DOI: 10.1002/ijc.28003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
41 Huang YK, Kang WM, Ma ZQ, Liu YQ, Zhou L, Yu JC. Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia: A case-control study among Chinese adults. Medicine (Baltimore) 2016;95:e4730. [PMID: 27583914 DOI: 10.1097/MD.0000000000004730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Yantiss RK, Samowitz WS. Molecular Pathology of Gastrointestinal Cancer. Surg Pathol Clin 2012;5:821-42. [PMID: 26838505 DOI: 10.1016/j.path.2012.08.002] [Reference Citation Analysis]
43 Coelho LGV, Marinho JR, Genta R, Ribeiro LT, Passos MDCF, Zaterka S, Assumpção PP, Barbosa AJA, Barbuti R, Braga LL, Breyer H, Carvalhaes A, Chinzon D, Cury M, Domingues G, Jorge JL, Maguilnik I, Marinho FP, Moraes-filho JPD, Parente JML, Paula-e-silva CMD, Pedrazzoli-júnior J, Ramos AFP, Seidler H, Spinelli JN, Zir JV. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arq Gastroenterol 2018;55:97-121. [DOI: 10.1590/s0004-2803.201800000-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
44 Shin SH, Jung DH, Kim JH, Chung HS, Park JC, Shin SK, Lee SK, Lee YC. Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia. PLoS One 2015;10:e0143257. [PMID: 26580072 DOI: 10.1371/journal.pone.0143257] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
45 Capelle LG, Haringsma J, de Vries AC, Steyerberg EW, Biermann K, van Dekken H, Kuipers EJ. Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Dig Dis Sci. 2010;55:3442-3448. [PMID: 20393882 DOI: 10.1007/s10620-010-1189-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
46 Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, Lee IS, Kim SW, Choi MG. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc 2016;83:1176-83. [PMID: 26522370 DOI: 10.1016/j.gie.2015.10.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
47 Niknam R, Manafi A, Fattahi MR, Mahmoudi L. The association between gastric endoscopic findings and histologic premalignant lesions in the Iranian rural population. Medicine (Baltimore) 2015;94:e715. [PMID: 25929902 DOI: 10.1097/MD.0000000000000715] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yantiss RK, Odze RD. Neoplastic precursor lesions of the upper gastrointestinal tract. Diagnostic Histopathology 2008;14:437-52. [DOI: 10.1016/j.mpdhp.2008.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Zulfiqar M, Bluth MH, Bhalla A. Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update. Clin Lab Med 2018;38:357-65. [PMID: 29776635 DOI: 10.1016/j.cll.2018.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
50 Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, Kim GH, Kim HU, Kim HY, Cho SI, Kim N. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7:303-310. [PMID: 23710311 DOI: 10.5009/gnl.2013.7.3.303] [Cited by in Crossref: 50] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
51 Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol. 2009;24:193-201. [PMID: 19215332 DOI: 10.1111/j.1440-1746.2008.05774.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
52 Park JM, Han YM, Hahm KB. Rejuvenation of Helicobacter pylori-Associated Atrophic Gastritis Through Concerted Actions of Placenta-Derived Mesenchymal Stem Cells Prevented Gastric Cancer. Front Pharmacol 2021;12:675443. [PMID: 34483897 DOI: 10.3389/fphar.2021.675443] [Reference Citation Analysis]
53 Holmes K, Egan B, Swan N, O'Morain C. Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics. 2007;8:379-397. [PMID: 19412438 DOI: 10.2174/138920207783406460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
54 de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945-952. [PMID: 18395075 DOI: 10.1053/j.gastro.2008.01.071] [Cited by in Crossref: 395] [Cited by in F6Publishing: 360] [Article Influence: 30.4] [Reference Citation Analysis]
55 Cha JM, Won KY, Chung IK, Kim GH, Lee SY, Cho YK. Effect of pronase premedication on narrow-band imaging endoscopy in patients with precancerous conditions of stomach. Dig Dis Sci. 2014;59:2735-2741. [PMID: 24861034 DOI: 10.1007/s10620-014-3218-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
56 Ward LS. Immune response in thyroid cancer: widening the boundaries. Scientifica (Cairo) 2014;2014:125450. [PMID: 25328756 DOI: 10.1155/2014/125450] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
57 González CA, Sanz-Anquela JM, Companioni O, Bonet C, Berdasco M, López C, Mendoza J, Martín-Arranz MD, Rey E, Poves E, Espinosa L, Barrio J, Torres MÁ, Cuatrecasas M, Elizalde I, Bujanda L, Garmendia M, Ferrández Á, Muñoz G, Andreu V, Paules MJ, Lario S, Ramírez MJ, Gisbert JP; Study group. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study. J Gastroenterol Hepatol 2016;31:953-8. [PMID: 26630310 DOI: 10.1111/jgh.13249] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
58 Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS. Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011;2011:387062. [PMID: 21403889 DOI: 10.4061/2011/387062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
59 刘敏黎, 屈亚威, 刘海峰. 内镜分子影像学诊断胃黏膜肠上皮化生的应用进展. 世界华人消化杂志 2016; 24(2): 203-208 [DOI: 10.11569/wcjd.v24.i2.203] [Reference Citation Analysis]
60 Chung SJ, Park MJ, Kang SJ, Kang HY, Chung GE, Kim SG, Jung HC. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. Int J Cancer. 2012;131:2376-2384. [PMID: 22362223 DOI: 10.1002/ijc.27501] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
61 Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1-7. [PMID: 21470209 DOI: 10.1111/j.1365-2249.2011.04384.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
62 Savarino E, Corbo M, Dulbecco P, Gemignani L, Giambruno E, Mastracci L, Grillo F, Savarino V. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol 2013; 19(17): 2668-2675 [PMID: 23674874 DOI: 10.3748/wjg.v19.i17.2668] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
63 Sokolova O, Naumann M. NF-κB Signaling in Gastric Cancer.Toxins (Basel). 2017;9:119. [PMID: 28350359 DOI: 10.3390/toxins9040119] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 22.3] [Reference Citation Analysis]